Enpp1 Deficiency
📧 Sign up to get email alerts when something new happens for Enpp1 Deficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency [Phase 1]
Phase 1 clinical trial update evaluating the safety and tolerability of INZ-701 in infants with ENPP1 or ABCC6 deficiencies.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: ENERGY 2: Evaluation of the Efficacy and Safety of INZ-701 in Infants With ENPP1 Deficiency [Phase 3]
This clinical trial update notes that INZ-701 is in Phase 3 trials to evaluate efficacy and safety in infants with ENPP1 deficiency, Autosom…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 Deficiency
PROPEL is a prospective observational patient registry sponsored by Inozyme Pharma to evaluate ENPP1 deficiency and ABCC6 deficiency. The re…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency [Phase 3]
Phase 3 clinical trial evaluating INZ-701 for ENPP1 deficiency in children, with ongoing status (ACTIVE_NOT_RECRUITING).
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 Deficiency [Phase 1, Phase 2]
This clinical trial update announces completion of Phase 1/2 evaluation of INZ-701 in adults with ENPP1 deficiency, assessing safety, tolera…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.